FLEXIZYME Secures Over €101M in Grant Funding to Revolutionize Sustainable Industrial Biotechnology

FLEXIZYME is proud to announce a major milestone in our journey towards revolutionizing industrial biotechnology. With the successful raising of 101,157,528 in funding, our company is well positioned to accelerate the transition towards environment-friendly, biotechnological industrial processes. As a 4-year project dedicated to transforming the industrial landscape, FLEXIZYME is focused on the circular valorisation of sustainable by-products, paving the way for the production of an array of cost-competitive bio-based products. This significant investment not only validates our vision but also enables us to expand our research and development efforts, which are designed to overcome current limitations in industrial biotechnology. At the heart of our mission lies the development of a robust and flexible platform that integrates a holistic approach, targeting upstream, midstream, and downstream processes simultaneously. By incorporating cutting-edge technologies, advanced biocatalyst engineering, and innovative reactor and process design, we are setting new standards in control and optimisation within the sector. Our interdisciplinary and systemic innovation approach positions FLEXIZYME to address key technological challenges, ultimately contributing to a more sustainable and eco-friendly industrial future. The funds raised will be strategically allocated to further research, expand our technical capabilities, and bolster collaborations that are essential for driving industry-wide transformation. As we move forward, we remain dedicated to ensuring that every step we take brings us closer to a world where sustainable practices and resource-efficient processes are the norm rather than the exception. This funding milestone is not just an investment in a project—it is a commitment to a cleaner, greener industrial future for all.